New York City, NY -- (SBWIRE) -- 12/16/2013 -- StockMarketIntel.com issues a special report on the following stocks: Five Star Quality Care, Inc. (NYSE:FVE), Bovie Medical Corporation (NYSEMKT:BVX), Alcobra Ltd (NASDAQ:ADHD), DRDGOLD Ltd. (ADR) (NYSE:DRD)
Five Star Quality Care, Inc. (NYSE:FVE) gained 10.80% recently, while trading on 404,634 shares, at the price of $5.14. The stock changed hands in a range of $5.11 to $5.39 up till now, bringing its market capitalization at about $248.60 million. If we look at its trading history of the past 52 weeks, the share price suffered a low of $4.41 and was moved to the maximum level of $6.87. Five Star Quality Care, Inc. operates and manages senior living communities in the United States. Its senior living communities include independent living communities, assisted living communities, and skilled nursing facilities (SNFs).
What was the Moving Force behind FVE on Bullish Run? Read This Research Report
Bovie Medical Corporation (NYSEMKT:BVX) added 10.05% recently, in the current trading session, at $2.30 with a total volume of 12,272 shares. The stock, on average, trades on a volume of 31,438 shares. It floated in a range of $2.28 to $2.45 during the recent trading session, with a beta value of 0.20. Its market capitalization now moved to about $41.00 million. In the past 52 weeks, the share price has not declined below $1.94 or above $4.79. Bovie Medical Corporation develops, manufactures, and markets medical products and devices with an emphasis on electrosurgical generators and electrosurgical disposables primarily in the United States.
For How Long BVX will fight for Profitability? Read This Trend Analysis report
Alcobra Ltd (NASDAQ:ADHD) recently recorded a gain of 3.27% and was moving within a range of $17.20-$20.00, its current trading price is $17.70. The stock is moving up till now with a total volume of 176,649 shares, versus an average volume of 61,934 shares. The share price hit its 52-week low of $6.50 and $26.96 was the best price. Alcobra Ltd., a biopharmaceutical company, focuses on the development and commercialization of various drugs for the treatment of neurological disturbance. Its principal product includes MG01CI that has completed Phase II studies to treat attention deficit hyperactivity disorder. The company was founded in 2008 and is headquartered in Tel Aviv, Israel.
For How Long ADHD Gloss will Attract Investors? Find out via this report
DRDGOLD Ltd. (ADR) (NYSE:DRD) added 17.52% in its current trading activity, bringing its market capitalization around $147.50 million. The share price, after opening at $3.30, hit a high of $3.90 and hovered above $3.30, while its recent trading price was $3.89. The total number of shares changed hands during the current session up till now was 93,421 shares, as compared to average trading volume of 79,560 shares. DRDGOLD Limited operates as a surface gold retreatment company in South Africa. It operates Ergo, a surface retreatment project that treats old slime and sand dumps to the south of Johannesburg?s central business district, as well as the east and central Rand goldfields.
Will DRD Continue To Move Higher? Find Out Here
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)